GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dynavax Technologies Corp (STU:DYF1) » Definitions » Inventories, Raw Materials & Components

Dynavax Technologies (STU:DYF1) Inventories, Raw Materials & Components : €30.7 Mil (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Dynavax Technologies Inventories, Raw Materials & Components?

Dynavax Technologies's inventories, raw materials & components for the quarter that ended in Sep. 2024 was €30.7 Mil.

Dynavax Technologies's quarterly raw materials increased from Mar. 2024 (€18.1 Mil) to Jun. 2024 (€22.4 Mil) and increased from Jun. 2024 (€22.4 Mil) to Sep. 2024 (€30.7 Mil).

Dynavax Technologies's annual raw materials increased from Dec. 2021 (€23.6 Mil) to Dec. 2022 (€24.1 Mil) and increased from Dec. 2022 (€24.1 Mil) to Dec. 2023 (€25.0 Mil).


Dynavax Technologies Inventories, Raw Materials & Components Historical Data

The historical data trend for Dynavax Technologies's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynavax Technologies Inventories, Raw Materials & Components Chart

Dynavax Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.68 20.65 23.57 24.09 24.99

Dynavax Technologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.74 24.99 18.09 22.42 30.67

Dynavax Technologies Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Dynavax Technologies Business Description

Industry
Traded in Other Exchanges
Address
2100 Powell Street, Suite 720, Emeryville, CA, USA, 94608
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Dynavax Technologies Headlines

No Headlines